Gsa Capital Partners LLP Fortress Biotech, Inc. Call Options Transaction History
Gsa Capital Partners LLP
- $1.32 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding FBIO
# of Institutions
5Shares Held
862KCall Options Held
0Put Options Held
0-
Cpwm, LLC Seattle, WA762KShares$1.24 Million0.06% of portfolio
-
Telemetry Investments, L.L.C. New York, NY72KShares$117,3590.07% of portfolio
-
Dowling & Yahnke LLC San Diego, CA20KShares$32,5990.01% of portfolio
-
Urban Wealth Management, LLC7.64KShares$12,4450.02% of portfolio
-
American Portfolios Advisors Holbrook, NY450Shares$7330.0% of portfolio
About Fortress Biotech, Inc.
- Ticker FBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,735,000
- Market Cap $176M
- Description
- Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...